Immunbetegségek biológiai alapjai (pl. autoimmunitás)
Klinikai orvostan
Orvos- és egészségtudomány
Reumatológia
Coronavirus disease 2019 (COVID-19) is associated with autoimmunity and systemic inflammation.
Patients with autoimmune rheumatic and musculoskeletal disease (RMD) may be at high
risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In
this review, based on evidence from the literature, as well as international scientific
recommendations, we review the relationships between COVID-19, autoimmunity and patients
with autoimmune RMDs, as well as the basics of a multisystemic inflammatory syndrome
associated with COVID-19. We discuss the repurposing of pharmaceutics used to treat
RMDs, the principles for the treatment of patients with autoimmune RMDs during the
pandemic and the main aspects of vaccination against SARS-CoV-2 in autoimmune RMD
patients.
